Mealtime Walking Study to Improve Postprandial Metabolic Response

Sponsor
Arizona State University (Other)
Overall Status
Completed
CT.gov ID
NCT04499287
Collaborator
(none)
10
3
5.7

Study Details

Study Description

Brief Summary

This randomized crossover trial will investigate the metabolic responses following the consumption of a bagel+juice meal under 3 conditions: control, fiber (positive control), and postmeal walk in15 healthy adults. It is hypothesized that the postmeal walk will reduce glycemia, insulinemia, and oxidative stress similar to fiber.

Condition or Disease Intervention/Treatment Phase
  • Other: 15-minute walk at preferred walking speed.
  • Dietary Supplement: Fiber
  • Other: control
N/A

Detailed Description

The study will follow a randomized, crossover design. Participants and the investigator will be blinded for the control treatments but not for the walk treatment. Participants will complete 3 meal tests; tests are separated by about 1 week. An initial screening visit will be scheduled for the online survey respondents that meet the inclusion criteria and are willing to consider participation. At this visit, written consent will be secured followed by further screening for the exclusion criteria and the collection of demographic and health history data and anthropometric measures. A fasting blood sample will be collected for glucose analysis. Participants will be scheduled for experimental testing and provided with instructions and calendars. Participants will be given at least one week's notice if they do not qualify for the trial based on fasting glucose concentrations.

On the day prior to each experimental day, the participants will consume 2 bagels (54 g carbohydrate/bagel), and on the night prior to each visit, participants will consume a standard dinner of their choice. (The bagels will be provided to participants and the standardized dinner will be documented. The bagels and standardized dinner meal will facilitate controlled 'glycogen loading' prior to testing.) No other food will be consumed after this dinner meal, and participants will fast overnight until they arrive at the research center the next morning (e.g., no food or beverage with the exception of water). Fasting blood (1 tablespoon) will be collected and the test meal (bagel+juice) will be consumed. Postprandial blood samples will be collected for 4 hours (see below). The subjects will not be allowed to consume any food or beverage (with the exception of water) through the duration the visit. A snack will be provided to participants once the testing is over.

Glucose: 0,15,30,60,120, 180, 240 Insulin: 0, 30, 120, 180, 240 Oxidative Stress Markers: 0, 180, 240

The blood insulin level will be determined in venous blood by RIA. Capillary blood glucose will be determined with a glucometer. Oxidative stress, e.g., total antioxidant capacity, IL-6, and TBARS will be assessed using microplate analyses kits.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
randomized, controlled, crossoverrandomized, controlled, crossover
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Mealtime Walking Study to Improve Postprandial Metabolic Response
Actual Study Start Date :
Sep 17, 2014
Actual Primary Completion Date :
Feb 14, 2015
Actual Study Completion Date :
Mar 10, 2015

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control

Test meal [bagel with butter (20 g) and apple juice (240 ml) with added sugar (24 g)] The meal was a total of 640 kcal (100 g carbohydrate, 21 g fat, 10 g protein. Participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption. One week later the test meal was consumed with fiber (36 g, Metamucil powder, Procter&Gamble, Cincinnati, OH) added to the apple juice (active) and participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption . One week later participants were given 5 minutes to transition to the treadmill following consumption of the test meal and began walking on a motorized treadmill at their calculated preferred walking speed for 15 minutes (experimental). Afterwards participants remained seated in the laboratory with minimal activity for the remainder of the four hours following test meal consumption

Other: 15-minute walk at preferred walking speed.

Dietary Supplement: Fiber
9 grams soluble fiber

Other: control
control

Active Comparator: Fiber

Test meal [bagel with butter (20 g) and apple juice (240 ml) with added sugar (24 g)] The meal was a total of 640 kcal (100 g carbohydrate, 21 g fat, 10 g protein. 9 grams of soluble viscous fiber from psyllium husk (36 g, Metamucil powder, Procter&Gamble, Cincinnati, OH) was mixed with the apple juice. Participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption. One week later participants were given 5 minutes to transition to the treadmill following consumption of the test meal and began walking on a motorized treadmill at their calculated preferred walking speed for 15 minutes (experimental). Afterwards participants remained seated in the laboratory with minimal activity for the remainder of the four hours following test meal consumption. One week later the test meal was consumed, and participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption (placebo).

Other: 15-minute walk at preferred walking speed.

Dietary Supplement: Fiber
9 grams soluble fiber

Other: control
control

Experimental: Walk

Test meal [bagel with butter (20 g) and apple juice (240 ml) with added sugar (24 g)] The meal was a total of 640 kcal (100 g carbohydrate, 21 g fat, 10 g protein. Participants were given 5 minutes to transition to the treadmill following consumption of the test meal and began walking on a motorized treadmill at their calculated preferred walking speed for 15 minutes. Afterwards participants remained seated in the laboratory with minimal activity for the remainder of the four hours following test meal consumption One week later the test meal was consumed, and participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption (placebo comparator). One week later the test meal was consumed with fiber (36 g, Metamucil powder, Procter&Gamble, Cincinnati, OH) added to the apple juice and participants remained seated in the laboratory with minimal activity for the four hours following test meal consumption (active comparator).

Other: 15-minute walk at preferred walking speed.

Dietary Supplement: Fiber
9 grams soluble fiber

Other: control
control

Outcome Measures

Primary Outcome Measures

  1. Postprandial glycemia [4 hours]

    incremental area under curve

  2. postprandial insulinemia [4 hours]

    incremental area under curve

Secondary Outcome Measures

  1. postprandial oxidative stress [4 hours]

    total antioxidant capacity of blood

  2. postprandial oxidative stress [4 hours]

    blood interleukin-6

  3. postprandial oxidative stress [4 hours]

    Thiobarbituric Acid Reactive Substances TBARS

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • obese (BMI ≥ 30 kg/m2)

  • nonsmoking

  • sedentary

  • fasting capillary blood glucose that measured from 5.6 to 6.9 mmol/L

Exclusion Criteria:
  • answered "yes" to any of the questions on the "Par-Q & You" questionnaire

  • refused to discontinue antioxidant supplement use for several weeks prior to and during the study

  • prescribed medication use (unless use was consistent for the 3 months prior to the study and intake remained consistent throughout the study duration)

  • food allergies or medical conditions that impacted normal functioning of the gastrointestinal tract

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Arizona State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carol Johnston, Professor and Associate Dean, Arizona State University
ClinicalTrials.gov Identifier:
NCT04499287
Other Study ID Numbers:
  • OxPMW
First Posted:
Aug 5, 2020
Last Update Posted:
Jul 23, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Carol Johnston, Professor and Associate Dean, Arizona State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 23, 2021